173 related articles for article (PubMed ID: 27503330)
1. A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database.
Ruzzenente A; Bagante F; Bertuzzo F; Aldrighetti L; Ercolani G; Giuliante F; Ferrero A; Torzilli G; Grazi GL; Ratti F; Cucchetti A; De Rose AM; Russolillo N; Cimino M; Perri P; Cataldo I; Scarpa A; Guglielmi A; Iacono C
J Gastrointest Surg; 2017 Jan; 21(1):41-48. PubMed ID: 27503330
[TBL] [Abstract][Full Text] [Related]
2. Multi-institutional Development and External Validation of a Nomogram Predicting Recurrence After Curative Liver Resection for Neuroendocrine Liver Metastasis.
Xiang JX; Zhang XF; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
Ann Surg Oncol; 2020 Oct; 27(10):3717-3726. PubMed ID: 32436187
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery.
Spolverato G; Bagante F; Aldrighetti L; Poultsides G; Bauer TW; Field RC; Marques HP; Weiss M; Maithel SK; Pawlik TM
J Gastrointest Surg; 2017 Dec; 21(12):2039-2047. PubMed ID: 28744737
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Extent of Liver Resection Among Patients with Neuroendocrine Liver Metastasis: an International Multi-institutional Study.
Sham JG; Ejaz A; Gage MM; Bagante F; Reames BN; Maithel S; Poultsides GA; Bauer TW; Fields RC; Weiss MJ; Marques HP; Aldrighetti L; Pawlik TM; He J
J Gastrointest Surg; 2019 Mar; 23(3):484-491. PubMed ID: 29980977
[TBL] [Abstract][Full Text] [Related]
5. Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter?
Xiang JX; Zhang XF; Beal EW; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
Ann Surg Oncol; 2018 Dec; 25(13):3928-3935. PubMed ID: 30218247
[TBL] [Abstract][Full Text] [Related]
6. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
[TBL] [Abstract][Full Text] [Related]
7. Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.
Zhang XF; Beal EW; Chakedis J; Lv Y; Bagante F; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Weiss M; Pawlik TM
J Gastrointest Surg; 2017 Nov; 21(11):1821-1830. PubMed ID: 28730354
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases.
Manguso N; Nissen N; Hendifar A; Harit A; Mirocha J; Friedman M; Lipshutz HG; Amersi F
J Surg Oncol; 2019 Nov; 120(6):926-931. PubMed ID: 31396982
[TBL] [Abstract][Full Text] [Related]
9. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
10. Early recurrence of well-differentiated (G1) neuroendocrine liver metastasis after curative-intent surgery: Risk factors and outcome.
Xiang JX; Zhang XF; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
J Surg Oncol; 2018 Dec; 118(7):1096-1104. PubMed ID: 30261105
[TBL] [Abstract][Full Text] [Related]
11. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection.
Liu W; Wang K; Han Y; Liang JY; Li YH; Xing BC
Eur J Surg Oncol; 2019 Nov; 45(11):2070-2077. PubMed ID: 31279595
[TBL] [Abstract][Full Text] [Related]
12. A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases.
Ye L; Ye H; Zhou Q; Li Z; Lin Q; Tan L; Gao W; Fu Z; Zheng S; Chen R
Int J Surg; 2016 May; 29():108-17. PubMed ID: 27000717
[TBL] [Abstract][Full Text] [Related]
13. Liver Resection for Neuroendocrine Tumor Liver Metastases Within Milan Criteria for Liver Transplantation.
Ruzzenente A; Bagante F; Bertuzzo F; Aldrighetti L; Campagnaro T; Ercolani G; Conci S; Giuliante F; Dore A; Ferrero A; Torzilli G; Grazi GL; Ratti F; Cucchetti A; De Rose AM; Russolillo N; Cimino M; Perri P; Guglielmi A; Iacono C
J Gastrointest Surg; 2019 Jan; 23(1):93-100. PubMed ID: 30242647
[TBL] [Abstract][Full Text] [Related]
14. Timing of disease occurrence and hepatic resection on long-term outcome of patients with neuroendocrine liver metastasis.
Zhang XF; Beal EW; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
J Surg Oncol; 2018 Feb; 117(2):171-181. PubMed ID: 28940257
[TBL] [Abstract][Full Text] [Related]
15. Predictive Profile-Nomogram for Liver Resection for Breast Cancer Metastases: An Aggressive Approach with Promising Results.
Ruiz A; Wicherts DA; Sebagh M; Giacchetti S; Castro-Benitez C; van Hillegersberg R; Paule B; Castaing D; Morère JF; Adam R
Ann Surg Oncol; 2017 Feb; 24(2):535-545. PubMed ID: 27573523
[TBL] [Abstract][Full Text] [Related]
16. Management of neuroendocrine tumor liver metastases.
Harrelson A; Wang R; Stewart A; Ingram C; Gillis A; Rose JB; El-Rayes B; Azmi A; Chen H
Am J Surg; 2023 Nov; 226(5):623-630. PubMed ID: 37657968
[TBL] [Abstract][Full Text] [Related]
17. Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors.
Pulvirenti A; Javed AA; Landoni L; Jamieson NB; Chou JF; Miotto M; He J; Gonen M; Pea A; Tang LH; Nessi C; Cingarlini S; D'Angelica MI; Gill AJ; Kingham TP; Scarpa A; Weiss MJ; Balachandran VP; Samra JS; Cameron JL; Jarnagin WR; Salvia R; Wolfgang CL; Allen PJ; Bassiy C
Ann Surg; 2021 Dec; 274(6):1051-1057. PubMed ID: 31567347
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract][Full Text] [Related]
19. Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from Asia.
Du S; Wang Z; Sang X; Lu X; Zheng Y; Xu H; Xu Y; Chi T; Zhao H; Wang W; Cui Q; Zhong S; Huang J; Mao Y
Medicine (Baltimore); 2015 Jan; 94(2):e388. PubMed ID: 25590842
[TBL] [Abstract][Full Text] [Related]
20. A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy.
Liang JY; Lin HC; Liu J; Wang DS; Yuan YF; Li BK; Zheng Y; Wu XJ; Chen G; Wang FH; Wang ZQ; Pan ZZ; Wan DS; Xu RH; Li YH
Cancer Med; 2021 Mar; 10(5):1535-1544. PubMed ID: 33539664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
